159 related articles for article (PubMed ID: 19662116)
1. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.
Dionysiou DD; Stamatakos GS; Gintides D; Uzunoglu N; Kyriaki K
Open Biomed Eng J; 2008 Sep; 2():43-51. PubMed ID: 19662116
[TBL] [Abstract][Full Text] [Related]
2. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.
Stamatakos GS; Antipas VP; Uzunoglu NK; Dale RG
Br J Radiol; 2006 May; 79(941):389-400. PubMed ID: 16632619
[TBL] [Abstract][Full Text] [Related]
3. A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy.
Stamatakos G; Antipas VP; Ozunoglu NK
Methods Inf Med; 2007; 46(3):367-75. PubMed ID: 17492124
[TBL] [Abstract][Full Text] [Related]
4. The genetic profile of a tumor as a determinant of its response to radiotherapy: a computer simulation of two different radiotherapeutic schemes.
Dionysiou DD; Peristeris T; Stamatakos GS; Nikita KS; Uzunoglu NK
Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3035-8. PubMed ID: 17270918
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme - an overview.
Urbańska K; Sokołowska J; Szmidt M; Sysa P
Contemp Oncol (Pozn); 2014; 18(5):307-12. PubMed ID: 25477751
[TBL] [Abstract][Full Text] [Related]
6. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation.
Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS; Marioli A
J Theor Biol; 2004 Sep; 230(1):1-20. PubMed ID: 15275995
[TBL] [Abstract][Full Text] [Related]
7. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
[TBL] [Abstract][Full Text] [Related]
8. A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe.
Bokstein F; Kovner F; Blumenthal DT; Ram Z; Templehoff H; Kanner AA; Corn BW
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):900-4. PubMed ID: 18407432
[TBL] [Abstract][Full Text] [Related]
9. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme.
Patel V; Hathout L
Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925
[TBL] [Abstract][Full Text] [Related]
10. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
Ginsberg T; Ulmer W; Düchting W
Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors Determining the Overall Outcome of Primary Spinal Glioblastoma Multiforme: An Integrative Survival Analysis.
Konar SK; Maiti TK; Bir SC; Kalakoti P; Bollam P; Nanda A
World Neurosurg; 2016 Feb; 86():341-8.e1-3. PubMed ID: 26348566
[TBL] [Abstract][Full Text] [Related]
12. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
Chang SM; Butowski NA; Sneed PK; Garner IV
Neurosurg Focus; 2006 Apr; 20(4):E4. PubMed ID: 16709035
[TBL] [Abstract][Full Text] [Related]
13. Malignant astrocytic gliomas in children.
Marchese MJ; Chang CH
Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
[TBL] [Abstract][Full Text] [Related]
14. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
15. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections.
Wesseling P; van der Laak JA; de Leeuw H; Ruiter DJ; Burger PC
J Neurosurg; 1994 Dec; 81(6):902-9. PubMed ID: 7525899
[TBL] [Abstract][Full Text] [Related]
17. In vitro split-dose recovery of glioblastoma multiforme.
Taghian A; Gioioso D; Budach W; Suit H
Radiat Res; 1993 Apr; 134(1):16-21. PubMed ID: 8386388
[TBL] [Abstract][Full Text] [Related]
18. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme.
Nakagawa K; Aoki Y; Fujimaki T; Tago M; Terahara A; Karasawa K; Sakata K; Sasaki Y; Matsutani M; Akanuma A
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1141-9. PubMed ID: 9539570
[TBL] [Abstract][Full Text] [Related]
19. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
Maroon J; Bost J; Amos A; Zuccoli G
J Child Neurol; 2013 Aug; 28(8):1002-8. PubMed ID: 23670248
[TBL] [Abstract][Full Text] [Related]
20. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
